Recent Conferences
October 14, 2010
Fall Forum
July 8, 2010
Summer Forum
April 15, 2010
Spring Forum
October 14, 2009
Accelerating High-Value Healthcare
September 16, 2009
Next Steps Toward a Robust Comparative Effectiveness Research Enterprise
July 20, 2009
Establishing a National Health Insurance Exchange
June 11, 2009
Federal Strategies for Promoting Affordable Biologics: Follow-On Biologic Competition
April 29, 2009
Implementing Bundled Payments for Health Care Services
November 24, 2008
Medicare Delivery System Reform
October 2, 2008
Specialty Pharmaceuticals: Policy Solutions for Encouraging Access and Affordability
July 16, 2008
Managing Specialty Pharmaceuticals
June 4, 2008
"Road Testing" Electronic Medical Records
April 30, 2008
Innovation Workgroup
April 10, 2008
Payment and Delivery System Reform
November 29, 2007
Comparative Effectiveness Congressional Briefing
November 27, 2007
Overview of Cost Management Strategies
October 24, 2007
Coverage With Evidence Development
October 2, 2007
Value-Based Payment for Medical Technologies
September 18, 2007
Personalized Medicine Conference
July 25, 2007
Comparative Effectiveness: Stakeholder Perspectives
April 11, 2007
Post Marketing Surveillance
February 14, 2007
Comparative Effectiveness Research: Congressional Briefing
November 30, 2006
Comparative Effectiveness Forum
October 12, 2006
Coverage Policy in an Era of Personalized Medicine
July 13, 2006
Pharmaceutical Benefit Management
May 1, 2006
Methodology Standards
April 4, 2006
Technology Assessment
October 3, 2005
Promoting Appropriate Utilization
April 1, 2005
Evidence-Based Health Care System
July 16, 2004
Correcting Underuse in Health Care
October 2, 2007
Value-Based Payment and Coverage for Medical Technologies
Over the next decade payers and purchasers will try to incorporate greater recognition of clinical value in payment policy and benefit design. Yet the practical aspects of these changes need to be articulated, tested, and refined. The purpose of this initial meeting is to begin discussing key principals, concepts, and challenges for value-based payment and coverage policy and to identify future research and policy development activities.
Presentations:
Growing Healthcare Spending: Is there a Role for Value Based Payment and Benefits Policy?
Stuart H. Altman, Ph.D., Dean and Sol C. Chaikin Professor, The Heller School for Social Policy and Management, Brandeis University
Value-Based Pricing and Purchasing for Drugs, Biotechnology, and Medical Devices
James C. Robinson, Editor in Chief, Health Affairs
Market Economics for Drugs and Biologicals
Luis T. Gutierrez, Jr., MBA, President, Covance Commercialization Services
The Science and Art of Value in Pricing for Medical Technology
Randel E. Richner, BSN, MPH, President, Founder, Neocure Bioeconomic Strategies
Realizing the Value of Minimally Invasive Surgery
Jacob Drapkin, Vice President, Ethicon Endo-Surgery Inc.
Cost Effectiveness & Pricing/Reimbursement / A Biotech Case Study
Scott Howell, MD, Senior Director, Channel and Contracting Strategy, Genentech
Practical Considerations for Value-Based Coverage and Payment Policy
Joseph Dorsey, MD, Former Corporate Medical Director, Harvard Pilgrim Health Care
Value-Based Payment for Medical Technologies: Five Propositions
Donald W. Moran, President, The Moran Company
Next Steps for Research and Policy Development
Sean Tunis, MD, MSc, Founder, Center for Medical Technology Policy
Paying for Value: International Developments
Kalipso Chalkidou, MD, Ph.D., Associate Director, Research and Development, NICE (UK)
